Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Patents
Molecular devices wins fundamental automated electrophysiology patent ruling
February 14th, 2007
Molecular Devices Corporation (MDCC), a provider of bioanalytical measurement systems for drug discovery and life sciences research, announced that the European Patent Office has upheld patent EP 1,040,349, a fundamental patent held by Molecular Devices relating to automated electrophysiology that was granted by the European Patent Office on September 5, 2001. On June 4, 2002 Nanion Technologies GmbH filed an opposition with the EPO requesting the revocation of the patent. The three person opposition board of the EPO examined the request and delivered a final opinion rejecting all grounds for the opposition on December 7, 2006. The '349 patent covers...
Source: Medical Patent Law Weekly (2007-02-14)
|
